Fetal gene therapy: opportunities and risks

Advances in human prenatal medicine and molecular genetics have allowed the diagnosis of many genetic diseases early in gestation. In-utero transplantation of allogeneic hematopoietic stem cells (HSC) has been successfully used as a therapy in different animal models and recently also in human fetuses. Unfortunately, clinical success of this novel treatment is limited by the lack of donor cell engraftment in non-immunocompromised hosts and is thus restricted to diseases where the fetus is affected by severe immunodeficiency. Gene therapy using genetically modified autologous HSC circumvents allogeneic HLA barriers and constitutes one of the most promising new approaches to correct genetic deficits in the fetus. Recent developments of strategies to overcome failure of efficient transduction of quiescent hematopoietic cells include the use of new vector constructs and transduction protocols. These improvements open new perspectives for gene therapy in general and for prenatal gene transfer in particular. The fetus may be especially susceptible for successful gene therapy due to the immunologic naiveté of the immature hematopoietic system during gestation, precluding an immune reaction towards the transgene. Ethical issues, in particular those regarding treatment safety, must be taken into account before clinical trials with fetal gene therapy in human pregnancies can be initiated.

Sensitive and highly specific quantitative real-time PCR and ELISA for recording a potential transfer of novel DNA and Cry1Ab protein from feed into bovine milk

To address food safety concerns of the public regarding the potential transfer of recombinant DNA (cry1Ab) and protein (Cry1Ab) into the milk of cows fed genetically modified maize (MON810), a highly specific and sensitive quantitative real-time PCR (qPCR) and an ELISA were developed for monitoring suspicious presence of novel DNA and Cry1Ab protein in bovine milk. The developed assays were validated according to the assay validation criteria specified in the European Commission Decision 2002/657/EC. The detection limit and detection capability of the qPCR and ELISA were 100 copies of cry1Ab microL(-1) milk and 0.4 ng mL(-1) Cry1Ab, respectively. Recovery rates of 84.9% (DNA) and 97% (protein) and low (<15%) imprecision revealed the reliable and accurate estimations. A specific qPCR amplification and use of a specific antibody in ELISA ascertained the high specificity of the assays. Using these assays for 90 milk samples collected from cows fed either transgenic (n = 8) or non-transgenic (n = 7) rations for 6 months, neither cry1Ab nor Cry1Ab protein were detected in any analyzed sample at the assay detection limits.

Inflammation induces hemorrhage in thrombocytopenia

The role of platelets in hemostasis is to produce a plug to arrest bleeding. During thrombocytopenia, spontaneous bleeding is seen in some patients but not in others; the reason for this is unknown. Here, we subjected thrombocytopenic mice to models of dermatitis, stroke, and lung inflammation. The mice showed massive hemorrhage that was limited to the area of inflammation and was not observed in uninflamed thrombocytopenic mice. Endotoxin-induced lung inflammation during thrombocytopenia triggered substantial intra-alveolar hemorrhage leading to profound anemia and respiratory distress. By imaging the cutaneous Arthus reaction through a skin window, we observed in real time the loss of vascular integrity and the kinetics of skin hemorrhage in thrombocytopenic mice. Bleeding-observed mostly from venules-occurred as early as 20 minutes after challenge, pointing to a continuous need for platelets to maintain vascular integrity in inflamed microcirculation. Inflammatory hemorrhage was not seen in genetically engineered mice lacking major platelet adhesion receptors or their activators (alphaIIbbeta3, glycoprotein Ibalpha [GPIbalpha], GPVI, and calcium and diacylglycerol-regulated guanine nucleotide exchange factor I [CalDAG-GEFI]), thus indicating that firm platelet adhesion was not necessary for their supporting role. While platelets were previously shown to promote endothelial activation and recruitment of inflammatory cells, they also appear indispensable to maintain vascular integrity in inflamed tissue. Based on our observations, we propose that inflammation may cause life-threatening hemorrhage during thrombocytopenia.

Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications

Mammalian members of the proton-coupled oligopeptide transporter family (SLC15) are integral membrane proteins that mediate the cellular uptake of di/tripeptides and peptide-like drugs. The driving force for uphill electrogenic symport is the chemical gradient and membrane potential which favors proton uptake into the cell along with the peptide/mimetic substrate. The peptide transporters are responsible for the absorption and conservation of dietary protein digestion products in the intestine and kidney, respectively, and in maintaining homeostasis of neuropeptides in the brain. They are also responsible for the absorption and disposition of a number of pharmacologically important compounds including some aminocephalosporins, angiotensin-converting enzyme inhibitors, antiviral prodrugs, and others. In this review, we provide updated information on the structure-function of PepT1 (SLC15A1), PepT2 (SLC15A2), PhT1 (SLC15A4) and PhT2 (SLC15A3), and their expression and localization in key tissues. Moreover, mammalian peptide transporters are discussed in regard to pharmacogenomic and regulatory implications on host pharmacology and disease, and as potential targets for drug delivery. Significant emphasis is placed on the evolving role of these peptide transporters as elucidated by studies using genetically modified animals. Whenever possible, the relevance of drug-drug interactions and regulatory mechanisms are evaluated using in vivo studies.

Repeat length and RNA expression level are not primary determinants in CUG expansion toxicity in Drosophila models.

Evidence for an RNA gain-of-function toxicity has now been provided for an increasing number of human pathologies. Myotonic dystrophies (DM) belong to a class of RNA-dominant diseases that result from RNA repeat expansion toxicity. Specifically, DM of type 1 (DM1), is caused by an expansion of CUG repeats in the 3'UTR of the DMPK protein kinase mRNA, while DM of type 2 (DM2) is linked to an expansion of CCUG repeats in an intron of the ZNF9 transcript (ZNF9 encodes a zinc finger protein). In both pathologies the mutant RNA forms nuclear foci. The mechanisms that underlie the RNA pathogenicity seem to be rather complex and not yet completely understood. Here, we describe Drosophila models that might help unravelling the molecular mechanisms of DM1-associated CUG expansion toxicity. We generated transgenic flies that express inducible repeats of different type (CUG or CAG) and length (16, 240, 480 repeats) and then analyzed transgene localization, RNA expression and toxicity as assessed by induced lethality and eye neurodegeneration. The only line that expressed a toxic RNA has a (CTG)(240) insertion. Moreover our analysis shows that its level of expression cannot account for its toxicity. In this line, (CTG)(240.4), the expansion inserted in the first intron of CG9650, a zinc finger protein encoding gene. Interestingly, CG9650 and (CUG)(240.4) expansion RNAs were found in the same nuclear foci. In conclusion, we suggest that the insertion context is the primary determinant for expansion toxicity in Drosophila models. This finding should contribute to the still open debate on the role of the expansions per se in Drosophila and in human pathogenesis of RNA-dominant diseases.

In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patient's hepatocytes.

BACKGROUND: Congenital afibrinogenemia is a rare inherited autosomal recessive disorder in which a mutation in one of three genes coding for the fibrinogen polypeptide chains Aα, Bβ and γ results in the absence of a functional coagulation protein. A patient with congenital afibrinogenemia, resulting from an FGA homozygous gene deletion, underwent an orthotopic liver transplant that resulted in complete restoration of normal hemostasis. The patient's explanted liver provided a unique opportunity to further investigate a potential novel treatment modality. OBJECTIVE: To explore a targeted gene therapy approach for patients with congenital afibrinogenemia. METHODS AND RESULTS: At the time of transplant, the patient's FGA-deficient hepatocytes were isolated and transduced with lentiviral vectors encoding the human fibrinogen Aα-chain. FGA-transduced hepatocytes produced fully functional fibrinogen in vitro. CONCLUSIONS: Orthotopic liver transplantation is a possible rescue treatment for failure of on-demand fibrinogen replacement therapy. In addition, we provide evidence that hepatocytes homozygous for a large FGA deletion can be genetically modified to restore Aα-chain protein expression and secrete a functional fibrinogen hexamer.

Regulatory sequences of the porcine THBD gene facilitate endothelial-specific expression of bioactive human thrombomodulin in single- and multitransgenic pigs.

BACKGROUND Among other mismatches between human and pig, incompatibilities in the blood coagulation systems hamper the xenotransplantation of vascularized organs. The provision of the porcine endothelium with human thrombomodulin (hTM) is hypothesized to overcome the impaired activation of protein C by a heterodimer consisting of human thrombin and porcine TM. METHODS We evaluated regulatory regions of the THBD gene, optimized vectors for transgene expression, and generated hTM expressing pigs by somatic cell nuclear transfer. Genetically modified pigs were characterized at the molecular, cellular, histological, and physiological levels. RESULTS A 7.6-kb fragment containing the entire upstream region of the porcine THBD gene was found to drive a high expression in a porcine endothelial cell line and was therefore used to control hTM expression in transgenic pigs. The abundance of hTM was restricted to the endothelium, according to the predicted pattern, and the transgene expression of hTM was stably inherited to the offspring. When endothelial cells from pigs carrying the hTM transgene--either alone or in combination with an aGalTKO and a transgene encoding the human CD46-were tested in a coagulation assay with human whole blood, the clotting time was increased three- to four-fold (P<0.001) compared to wild-type and aGalTKO/CD46 transgenic endothelial cells. This, for the first time, demonstrated the anticoagulant properties of hTM on porcine endothelial cells in a human whole blood assay. CONCLUSIONS The biological efficacy of hTM suggests that the (multi-)transgenic donor pigs described here have the potential to overcome coagulation incompatibilities in pig-to-primate xenotransplantation.

Investigation of retinal morphology alterations using spectral domain optical coherence tomography in a mouse model of retinal branch and central retinal vein occlusion.

Retinal vein occlusion is a leading cause of visual impairment. Experimental models of this condition based on laser photocoagulation of retinal veins have been described and extensively exploited in mammals and larger rodents such as the rat. However, few reports exist on the use of this paradigm in the mouse. The objective of this study was to investigate a model of branch and central retinal vein occlusion in the mouse and characterize in vivo longitudinal retinal morphology alterations using spectral domain optical coherence tomography. Retinal veins were experimentally occluded using laser photocoagulation after intravenous application of Rose Bengal, a photo-activator dye enhancing thrombus formation. Depending on the number of veins occluded, variable amounts of capillary dropout were seen on fluorescein angiography. Vascular endothelial growth factor levels were markedly elevated early and peaked at day one. Retinal thickness measurements with spectral domain optical coherence tomography showed significant swelling (p<0.001) compared to baseline, followed by gradual thinning plateauing two weeks after the experimental intervention (p<0.001). Histological findings at day seven correlated with spectral domain optical coherence tomography imaging. The inner layers were predominantly affected by degeneration with the outer nuclear layer and the photoreceptor outer segments largely preserved. The application of this retinal vein occlusion model in the mouse carries several advantages over its use in other larger species, such as access to a vast range of genetically modified animals. Retinal changes after experimental retinal vein occlusion in this mouse model can be non-invasively quantified by spectral domain optical coherence tomography, and may be used to monitor effects of potential therapeutic interventions.

Intervertebral Disc Repair using Fleece-Membrane Composite Silk Material and Genipin-enhanced Fibrin Hydrogel

Introduction: Treating low back pain (LBP) has become an increasing challenge, as it is one of the main factors causing pain and is accompanied by high costs for the individual and the society. LBP can be caused by trauma of the intervertebral disc (IVD) or IVD degeneration. In the case of disc herniation the inner gelatinous part of the IVD, called nucleus pulposus, is pressed through the fibrous, annulus fibrosus that forms the outer part of the IVD. Today’s gold standard for treatment is extensive surgery as removal of the IVD and fusion of the vertebrae. In order to find a more gentle way to treat LBP and restore the native IVD we use a novel silk fleece-membrane composite from genetically modified silk worms whose silk contains a growth factor (GDF-6) that is associated with pushing stem cells towards a disc like phenotype (1). By combining it with a genipin-enhanced fibrin hydrogel we tested its suitability in organ culture on prior injured bovine IVD in our custom built two-degree of freedom bioreactor to mimic natural loading conditions. Material & Methods: Bovine IVDs of 12-17 months old animals were isolated by first removing all surrounding tissue followed by cutting out the IVDs as previously described (2). Culturing of discs occurred in high glucose Dulbecco's Modified Eagle Medium (HG-DMEM) supplemented with 5% serum as previously described (2). On the next day injury was induced using a 2mm biopsy punch (Polymed, Switzerland). The formed cavity was filled with (0.4%) genipin-enhanced human based fibrin hydrogel (35-55mg/mL human fibrinogen, Baxter, Austria) and sealed with a silk fleece-membrane composite (Spintec Engineering, Germany). Different culture conditions were applied: free swelling, static diurnal load of 0.2MPa for 8h/d and complex loading at 0.2MPa compression combined with ± 2° torsion at 0.2Hz for 8h/d (2). After 14 days of culture cell activity was determined with resazurin assay. Additionally, glycosaminoglycan (dimethyl-methylene blue), DNA (Hoechst) and collagen content (hydroxy- proline) were determined. Finally, real-time qPCR of major IVD marker and inflammation genes was performed to judge integrity of IVDs. Results: The fibrin hydrogel is able to keep the silk seal in place throughout the 14 days of in organ culture under all conditions. Additionally, cell activity showed optimistic results and we could not confirm negative effects of the repaired discs regarding overexpression of inflammation markers. Conclusions: The genipin-enhanced fibrin hydrogel in combination with the silk fleece- membrane composite seems to be a promising approach for IVD repair. Currently we assess the capability of GDF-6 incorporated in our silk composites on human mesenchymal stem cells and later on in organ culture. References 1. Clarke LE, McConnell JC, Sherratt MJ, Derby B, Richardson SM, Hoyland JA. Growth differentiation factor 6 and transforming growth factor-beta differentially mediate mesenchymal stem cell differentiation, composition and micromechanical properties of nucleus pulposus constructs. Arthritis Res Ther 2014, Mar 12;16(2):R67. 2. Chan SC, Gantenbein-Ritter B. Preparation of intact bovine tail intervertebral discs for organ culture. J Vis Exp 2012, Feb 2;60(60):e3490. Acknowledgements. This work is funded by the Gebert Rüf Foundation, project number GRS-028/13.

Aceptación de aceite transgénico de distinto país de origen en la Región de La Araucanía, Chile

Considerando el rechazo de los consumidores hacia alimentos genéticamente modificados y que el país de origen es usado como indicador de calidad, se estudió la importancia relativa de la existencia de modificación genética (MG), origen y precio en la compra de aceite de girasol en Temuco, Chile, junto con la identificación y la caracterización de diferentes segmentos de mercado, mediante una encuesta a 400 personas. Utilizando análisis conjunto se determinó que la existencia de MG (36,0%) fue levemente más importante que el origen (33,3%) y el precio (30,7%) en la muestra total, con preferencia hacia el producto sin MG, de origen chileno y al menor precio. Mediante análisis de conglomerados jerárquicos se diferenciaron tres segmentos: el mayoritario (45,5%) dio elevada importancia a la existencia de MG y presentó un alto rechazo hacia el aceite transgénico; el segundo grupo (29,7%) asignó mayor relevancia al precio y acepta aceite argentino; el grupo minoritario (24,8%) otorgó mayor importancia al origen y acepta aceite español. Independientemente de lo anterior, los grupos mostraron mayor preferencia por el aceite chileno. La ausencia de MG en aceite es una condición deseable para una importante proporción de consumidores (45,5%), pero el resto se muestra relativamente indiferente hacia la existencia o ausencia de manipulación genética en este producto.

Transformaciones y conflictos en el agro chaqueño durante los ´90. Articulaciones territoriales de una nueva racionalidad productiva

Las transformaciones ocurridas en el sector agrícola del Chaco en los ´90, constituyen un ejemplo concreto de procesos de desarrollo geográfico desigual. A partir de 1999 esta provincia, dejó de ser la principal productora algodonera argentina para incorporarse a la siembra de soja genéticamente modificada, convertida en el principal cultivo nacional. El reemplazo de una lógica productiva que sustentó la organización económica y social provincial durante más de cuatro décadas por otra que privilegió la eficiencia y los menores costos comparativos, suscitó conflictos y reacciones diferenciales en el sector según la vulnerabilidad selectiva de los actores involucrados. El objetivo del trabajo es profundizar en ese proceso de reemplazo, estableciendo las principales características de las transformaciones acontecidas y dimensionando tanto sus efectos, como las respuestas de los distintos agentes del sector (una mayoría de pequeños productores tradicionales apoyados por organizaciones no gubernamentales, una minoría de medianos y grandes productores empresarios y el gobierno provincial)

Transformaciones y conflictos en el agro chaqueño durante los ´90. Articulaciones territoriales de una nueva racionalidad productiva

Las transformaciones ocurridas en el sector agrícola del Chaco en los ´90, constituyen un ejemplo concreto de procesos de desarrollo geográfico desigual. A partir de 1999 esta provincia, dejó de ser la principal productora algodonera argentina para incorporarse a la siembra de soja genéticamente modificada, convertida en el principal cultivo nacional. El reemplazo de una lógica productiva que sustentó la organización económica y social provincial durante más de cuatro décadas por otra que privilegió la eficiencia y los menores costos comparativos, suscitó conflictos y reacciones diferenciales en el sector según la vulnerabilidad selectiva de los actores involucrados. El objetivo del trabajo es profundizar en ese proceso de reemplazo, estableciendo las principales características de las transformaciones acontecidas y dimensionando tanto sus efectos, como las respuestas de los distintos agentes del sector (una mayoría de pequeños productores tradicionales apoyados por organizaciones no gubernamentales, una minoría de medianos y grandes productores empresarios y el gobierno provincial)

Transformaciones y conflictos en el agro chaqueño durante los ´90. Articulaciones territoriales de una nueva racionalidad productiva

Las transformaciones ocurridas en el sector agrícola del Chaco en los ´90, constituyen un ejemplo concreto de procesos de desarrollo geográfico desigual. A partir de 1999 esta provincia, dejó de ser la principal productora algodonera argentina para incorporarse a la siembra de soja genéticamente modificada, convertida en el principal cultivo nacional. El reemplazo de una lógica productiva que sustentó la organización económica y social provincial durante más de cuatro décadas por otra que privilegió la eficiencia y los menores costos comparativos, suscitó conflictos y reacciones diferenciales en el sector según la vulnerabilidad selectiva de los actores involucrados. El objetivo del trabajo es profundizar en ese proceso de reemplazo, estableciendo las principales características de las transformaciones acontecidas y dimensionando tanto sus efectos, como las respuestas de los distintos agentes del sector (una mayoría de pequeños productores tradicionales apoyados por organizaciones no gubernamentales, una minoría de medianos y grandes productores empresarios y el gobierno provincial)

Diseño de una práctica para un laboratorio virtual de biotecnología multilingüe y adaptable a alumnos de secundaria

Este trabajo describe el diseño y la implementación de un ejercicio virtual que es parte de una práctica que se realiza en un laboratorio virtual de biotecnología, la adaptación de la misma para que alumnos de secundaria la puedan realizar y por último, la adaptación del laboratorio a un entorno multilingüe. La práctica consiste en transformar genéticamente un árbol (chopo) para dotarlo de una mayor resistencia a enfermedades, especialmente las producidas por hongos y más en concreto, el ejercicio o fase de la práctica a desarrollar consiste en introducir en el plásmido un gen amplificado por la PCR obtenido en la fase anterior de la práctica virtual. La adaptación para alumnos de secundaria servirá para fomentar el interés de estos alumnos por la biotecnología. Asimismo, la adaptación a un entorno multilingüe permitirá que varios alumnos de distintos idiomas realicen la práctica de forma simultánea. Como parte de este trabajo, se ha realizado un análisis sobre OpenSimulator, que es la herramienta utilizada para la creación del entorno virtual, así como de sus visores gráficos para visitar y desarrollar el mundo virtual. Debido a que este proyecto toma como punto de partida un laboratorio virtual con una parte de la práctica virtual ya desarrollada, se ha incluido una descripción de dicho laboratorio para comprender mejor el trabajo que se ha realizado en este proyecto. Finalmente, en este trabajo se presentan los modelos y especificaciones para la extensión del laboratorio virtual. ---ABSTRACT---This document describes the design and implementation of virtual exercise that is part of a practice that is performed in a virtual biotechnology laboratory, the adaptation of this phase to high-school students and finally, the adaptation of laboratory for a multilingual environment. In this practice a tree is genetically modified to give it resistance to diseases produced by fungi. Specifically, the exercise or phase developed consists in introducing in the plasmid a gene amplified by PCR in the previous phase. The adaptation for high-school students will motivate to new students about biotechnology. And the adapting to the multilingual environment will allow several students, such as Erasmus, to do the practice in different languages simultaneously. We analyzed the OpenSimulator platform and the graphic viewers to visit and develop the virtual world. This tool is used for creating the virtual environment. Because of the fact that the project takes a starting point a laboratory with some parts already developed, we have included a description with information related to the laboratory to better understand the work carried out in this project. Finally, this document presents the models and specifications for the extension of the virtual laboratory.

Dynamic characteristics and adaptability of mouse vestibulo-ocular and optokinetic response eye movements and the role of the flocculo-olivary system revealed by chemical lesions

The dynamic characteristics of reflex eye movements were measured in two strains of chronically prepared mice by using an infrared television camera system. The horizontal vestibulo-ocular reflex (HVOR) and horizontal optokinetic response (HOKR) were induced by sinusoidal oscillations of a turntable, in darkness, by 10° (peak to peak) at 0.11–0.50 Hz and of a checked-pattern screen, in light, by 5–20°at 0.11–0.17 Hz, respectively. The gains and phases of the HVOR and HOKR of the C57BL/6 mice were nearly equivalent to those of rabbits and rats, whereas the 129/Sv mice exhibited very low gains in the HVOR and moderate phase lags in the HOKR, suggesting an inherent sensory-motor anomaly. Adaptability of the HOKR was examined in C57BL/6 mice by sustained screen oscillation. When the screen was oscillated by 10° at 0.17 Hz, which induced sufficient retinal slips, the gain of the HOKR increased by 0.08 in 1 h on average, whereas the stimuli that induced relatively small or no retinal slips affected the gain very little. Lesions of the flocculi induced by local applications of 0.1% ibotenic acid and lesions of the inferior olivary nuclei induced by i.p. injection of 3-acetylpyridine in C57BL/6 mice little affected the dynamic characteristics of the HVOR and HOKR, but abolished the adaptation of the HOKR. These results indicate that the olivo-floccular system plays an essential role in the adaptive control of the ocular reflex in mice, as suggested in other animal species. The data presented provide the basis for analyzing the reflex eye movements of genetically engineered mice.